Author

Manuela Le Bars 1

1 Janssen-Cilag,Issy les Moulineaux,France

CLINICAL AND ENDOSCOPIC RESPONSE TO TREAT-TO-TARGET VERSUS STANDARD OF CARE IN CROHN'S DISEASE PATIENTS TREATED WITH USTEKINUMAB: WEEK 48 RESULTS OF THE STARDUST TRIAL

Silvio Danese, Severine Vermeire, Geert R. D'Haens, Julian Panés, Axel Dignass, Fernando Jose Magro Dias, Maciek Nazar, Manuela Le Bars, Marjolein Lahaye, Lioudmila Ni, Fréderic Lavie, Ivana Bravata, Sheldon Sloan, Marco Daperno, Milan Lukas, Alessandro Armuzzi, Mark Lowenberg, Daniel R. Gaya, Laurent Peyrin-Biroulet

INTESTINAL ULTRASOUND RESPONSE AND TRANSMURAL HEALING AFTER 48 WEEKS OF TREATMENT WITH USTEKINUMAB IN CROHN'S DISEASE: STARDUST TRIAL SUBSTUDY

Torsten Kucharzik, Rune Wilkens, Giovanni Maconi, Maria-Antonietta D’Agostino, Manuela Le Bars, Marjolein Lahaye, Ivana Bravata, Maciek Nazar, Lioudmila Ni, Elena Ercole, Mariangela Allocca, Nadezda Machkova, Floris de Voogd, Carolina Palmela, Rose Vaughan, Christian Maaser

PHARMACOKINETICS, IMMUNOGENICITY, AND EXPOSURE-RESPONSE RELATIONSHIP OF USTEKINUMAB IN PATIENTS WITH CROHN'S DISEASE: RESULTS FROM THE WEEK 16 INTERIM ANALYSIS OF THE STARDUST STUDY

Geert D’Haens, Omoniyi J. Adedokun, Silvio Danese, Severine Vermeire, Julian Panés, Axel Dignass, Fernando Jose Magro Dias, Maciek Nazar, Manuela Le Bars, Marjolein Lahaye, Lioudmila Ni, Daniel R. Gaya, Laurent Peyrin-Biroulet

USTEKINUMAB IMPROVES HEALTH-RELATED QUALITY-OF-LIFE IN PATIENTS WITH MODERATE-TO-SEVERE CROHN´S DISEASE: RESULTS FROM A WEEK 16 INTERIM ANALYSIS OF THE STARDUST TRIAL

Silvio Danese, Severine Vermeire, Geert R. D'Haens, Julian Panés, Axel Dignass, Fernando Jose Magro Dias, Maciek Nazar, Manuela Le Bars, Marjolein Lahaye, Lioudmila Ni, Daniel R. Gaya, Laurent Peyrin-Biroulet

Item 1 - 4 / 4
1